Skip to Main Content

Author Details

Stephen Greco
Johns Hopkins University School of Medicine
2012
32
13
PMIDPaper TitleJournal TitlePublished Year
36316967The impact of salvage radiotherapy initiation at PSA⿿⿤⿿0.5⿿ng/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy.Prostate2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
36367998Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.J Clin Oncol2023
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
35478055Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.Med Oncol2022
37008272Improving Quality Metrics in Radiation Oncology: Implementation of Pretreatment Peer Review for Stereotactic Body Radiation Therapy in Patients with Thoracic Cancer.Adv Radiat Oncol2022
35014708Radiating the prostate bed in relapsed oligometastatic prostate cancer: How comprehensive should we be?Prostate2022
35013522Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.Prostate Cancer Prostatic Dis2022
32536574Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer.Eur Urol Oncol2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
32798608Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer.Int J Radiat Oncol Biol Phys2021
30992160Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.Eur Urol2020
33090219Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.JAMA Oncol2020
32215577Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.JAMA Oncol2020
32487038A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).BMC Cancer2020
32292844An Integrated Program in a Pandemic: Johns Hopkins Radiation Oncology Department.Adv Radiat Oncol2020
31454660Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.Urology2020
30860866Utility of a Clinical Decision Support System in Weight Loss Prediction After Head and Neck Cancer Radiotherapy.JCO Clin Cancer Inform2019
31196032A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).BMC Cancer2019
31419509Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience.Int J Radiat Oncol Biol Phys2019
30738769Patterns of Incident Reporting Across Clinical Sites in a Regionally Expanding Academic Radiation Oncology Department.J Am Coll Radiol2019
29509865Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.JAMA2018
29976500Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.Int J Radiat Oncol Biol Phys2018
29551548Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy.Urol Oncol2018
29520847Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate-risk prostate cancer at high risk of distant recurrence and cancer-specific mortality.Prostate2018
28662647A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).BMC Cancer2017
28094250End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer.Prostate Cancer Prostatic Dis2017
28410187Comparing Web-Based Provider-Initiated and Patient-Initiated Survivorship Care Planning for Cancer Patients: A Randomized Controlled Trial.JMIR Cancer2016
24599884Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging.Exp Biol Med (Maywood)2014
22909061Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152.Mol Cancer2012
  • 1 - 32 of 32

Recommended Authors

Audrey Dang
Tulane University School of Medicine
Career Start Year 2018
Number of shared co-authors 25
Chenyang Wang
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2017
Number of shared co-authors 20
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 26
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 21
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 5
Adam B Weiner
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 30
Neil R Parikh
San Antonio Cancer Center
Career Start Year 2012
Number of shared co-authors 36
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 8
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 19
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 3
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 7
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 10
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 23
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 17
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 3
Nima Aghdam
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 25
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 44
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 10
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 32
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 41
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 7
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 25
Simeng Suy
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 26
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 16
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 25
Jeff M Michalski
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 53
Fred Saad
University of Montreal Health Center
Career Start Year 1990
Number of shared co-authors 30
Mack Roach
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 62
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 61

Collaborators

Curtiland Deville
Johns Hopkins University
Co-authored papers 26
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 26
Danny Y Song
Johns Hopkins University School of Medicine
Co-authored papers 25
Theodore L DeWeese
Johns Hopkins University School of Medicine
Co-authored papers 25
Todd McNutt
Johns Hopkins University School of Medicine
Co-authored papers 16
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 11
Ashley E Ross
Northwestern University
Co-authored papers 10
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 9
Michael A Carducci
Johns Hopkins School of Medicine
Co-authored papers 9
Channing J Paller
Johns Hopkins University School of Medicine
Co-authored papers 9
Amar U Kishan
University of California los angeles
Co-authored papers 9
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 9
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Co-authored papers 9
Jay P Ciezki
Cleveland Clinic
Co-authored papers 8
Ryan Fiano
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 8
Daniel J Krauss
William Beaumont School of Medicine
Co-authored papers 8
Bradley J Stish
Mayo Clinic
Co-authored papers 8
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 8
Gregory S Merrick
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 8
Richard G Stock
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Mario A Eisenberger
Johns Hopkins University
Co-authored papers 8
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 8
Eyad Abu-Isa
Ascension Providence Hospital
Co-authored papers 8
Wolfgang Lilleby
Oslo University Hospital
Co-authored papers 8
Michael L Steinberg
University of California los angeles
Co-authored papers 8
David Jeffrey Demanes
University of California los angeles
Co-authored papers 8
Trude B Wedde
Oslo University Hospital
Co-authored papers 8
Chandana A Reddy
Cleveland Clinic
Co-authored papers 8
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 8
Ryan Phillips
Johns Hopkins University
Co-authored papers 8
Release 1.2